RESEARCH PHARMACEUTICAL SERVICES, INC. Contracts & Agreements

31 Contracts & Agreements

Browse by Contract Category

Contracts

AGREEMENT AND PLAN OF MERGER by and among ROY RPS HOLDINGS CORP. RPS MERGER SUB INC. and RESEARCH PHARMACEUTICAL SERVICES, INC. dated as of DECEMBER 27, 2010 (Filed With SEC on December 28, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on November 23, 2010)
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on November 2, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
Continued growth in outsourced research and development spendingGrowth in our industry derives both from growth in the research and development budgets of the biopharmaceutical... (Filed With SEC on June 18, 2010)
THIRD AMENDMENT (Filed With SEC on November 13, 2009)